Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 Akedo Akedo +48.58%
#3 DOVU DOVU +47.59%
#4 Velvet Velvet +38.22%
#5 Black Phoenix Black Phoenix +34.27%
#6 Cross Cross +19.42%
#7 DoubleZero DoubleZero +17.37%
#8 Cap Cap +16.79%
#9 Tutorial Tutorial +15.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.89%
Coin of the day
Islamic Coin Islamic Coin
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Aequus Pharmaceuticals Inc. Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.

AQS
Xếp hạng trong cổ phiếu #39477
Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company... Aequus Pharmaceuticals Inc. is a specialized Canadian pharmaceutical company dedicated to advancing and commercializing therapeutic solutions. Its core operations span critical areas such as neurology, ophthalmology, and transplantation. The company currently markets a range of products, including Vistitan, an ophthalmic treatment designed to alleviate elevated intraocular pressure in individuals suffering from open-angle glaucoma or ocular hypertension. Another key offering is Tacrolimus IR, an immunosuppressant vital for both preventing and treating acute rejection in organ transplant recipients. Aequus also provides its Evolve line of dry eye products, which target various symptoms associated with dry eye disease and blepharitis, such as discomfort, stinging, burning, and dryness, alongside a preservative-free ophthalmic option. In its development pipeline, Aequus is progressing several innovative candidates. These include Topiramate XR and Oxcarbazepine XR, extended-release oral tablets aimed at epilepsy treatment; AQS1303, a transdermal formulation of pyridoxine/doxylamine developed to combat nausea and vomiting during pregnancy; and AQS1304, a cannabinoid-based therapeutic under investigation for neurological disorders. To support its market reach and innovation, Aequus has forged strategic alliances. These include an agreement with Sandoz Canada, Inc. for the promotion of Vistitan; a partnership with Supernus Pharmaceuticals, Inc. for the marketing of its extended-release anti-epileptic drugs; and a collaboration with Medicom Healthcare Ltd. centered on preservative-free ophthalmic treatments. Established in 2013, Aequus Pharmaceuticals Inc. maintains its corporate headquarters in Vancouver, Canada.
Giá cổ phiếu
$0.00359455
Đồng bộ lần cuối: 2025-05-20
Vốn hóa thị trường
$476.76K
Thay đổi (1 ngày)
0.44%
Thay đổi (1 năm)
0.00%
Quốc gia
CA
Giao dịch Aequus Pharmaceuticals Inc. (AQS)

Danh mục

Healthcare
Lịch sử chia tách cổ phiếu của Aequus Pharmaceuticals Inc. (AQS)
Cổ phiếu Aequus Pharmaceuticals Inc. (mã: AQS) đã trải qua tổng cộng 0 lần chia tách.
Lần chia tách gần nhất diễn ra vào ngày Aug 14, 2026.
Một cổ phiếu AQS mua trước ngày Aug 14, 2026 hiện tương đương với 0 cổ phiếu AQS.
Danh sách chia tách cổ phiếu
Năm Chia tách Tỷ lệ Tỷ lệ cộng dồn
Không đủ dữ liệu cho ngày được cung cấp.
Chia tách cổ phiếu của các công ty tương tự hoặc đối thủ
Công ty Số lần chia tách cổ phiếu Tỷ lệ cộng dồn Quốc gia
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 0 -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 0 -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 0 -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 0 -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 5 x119
IN